None
Quote | Vaxil Bio (OTCMKTS:VXLLF)
Last: | $0.007 |
---|---|
Change Percent: | 0.0% |
Open: | $0.007 |
Close: | $0.007 |
High: | $0.007 |
Low: | $0.007 |
Volume: | 50,000 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Vaxil Bio (OTCMKTS:VXLLF)
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” o...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” or...
Message Board Posts | Vaxil Bio (OTCMKTS:VXLLF)
Subject | By | Source | When |
---|---|---|---|
Now it's over a year since the last | skitahoe | investorshub | 04/09/2023 5:38:08 AM |
About 50 weeks since the last post here, | Hikerbc | investorshub | 02/05/2022 3:25:15 AM |
New video out: | anotrade | investorshub | 02/18/2021 4:47:44 PM |
Thanks, I think the potential here is great enough | skitahoe | investorshub | 02/17/2021 10:40:39 PM |
Vaxil just released an update and it wasn't | anotrade | investorshub | 02/17/2021 10:07:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” o...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” or...
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (" Vaxil " or the " Company ") (TSX VENTURE:VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases announces the follow update on its research activities and changes in seni...